Symbol:
Crabp2
Name:
cellular retinoic acid binding protein 2
RGD ID:
62070
Description:
Enables retinoic acid binding activity. Involved in retinoic acid biosynthetic process. Predicted to be located in endoplasmic reticulum and nucleoplasm. Predicted to be active in cytosol and nucleus. Orthologous to human CRABP2 (cellular retinoic acid binding protein 2); PARTICIPATES IN retinoic acid metabolic pathway; INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 4-tert-Octylphenol; 9-cis-retinoic acid.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
cellular lipid-binding protein; cellular retinoic acid binding protein II; cellular retinoic acid-binding protein 2; cellular retinoic acid-binding protein 2-like; cellular retinoic acid-binding protein II; CRABP-II; LOC108348208
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 2 175,714,862 - 175,719,208 (+) NCBI GRCr8 mRatBN7.2 2 173,417,004 - 173,421,352 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 2 173,416,857 - 173,421,379 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 2 180,561,789 - 180,566,132 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 2 178,584,144 - 178,588,487 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 2 173,184,231 - 173,188,583 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 2 187,322,416 - 187,326,794 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 2 184,882,969 - 184,883,505 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 2 204,274,043 - 204,274,530 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 2 180,029,801 - 180,034,147 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 2 167,367,701 - 167,368,833 (+) NCBI Celera Cytogenetic Map 2 q34 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Crabp2 Rat (R,R,R)-alpha-tocopherol multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [Tretinoin co-treated with alpha-Tocopherol] results in increased expression of CRABP2 mRNA and [Tretinoin co-treated with alpha-Tocopherol] results in increased expression of CRABP2 protein CTD PMID:15225641 Crabp2 Rat (S)-nicotine decreases expression ISO CRABP2 (Homo sapiens) 6480464 Nicotine results in decreased expression of CRABP2 mRNA CTD PMID:16949557 Crabp2 Rat 1,2-dichloroethane increases expression ISO Crabp2 (Mus musculus) 6480464 ethylene dichloride results in increased expression of CRABP2 mRNA CTD PMID:28960355 Crabp2 Rat 17alpha-ethynylestradiol increases expression ISO Crabp2 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of CRABP2 mRNA CTD PMID:17942748 Crabp2 Rat 17alpha-ethynylestradiol multiple interactions ISO Crabp2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CRABP2 mRNA CTD PMID:17942748 Crabp2 Rat 17beta-estradiol multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of CRABP2 mRNA and [Progesterone co-treated with Estradiol] results in decreased expression of CRABP2 mRNA CTD PMID:17404688 and PMID:30165855 Crabp2 Rat 17beta-estradiol decreases expression ISO CRABP2 (Homo sapiens) 6480464 Estradiol results in decreased expression of CRABP2 mRNA CTD PMID:23019147 Crabp2 Rat 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO Crabp2 (Mus musculus) 6480464 2 more ... CTD PMID:31388691 Crabp2 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Crabp2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CRABP2 mRNA and Tetrachlorodibenzodioxin inhibits the reaction [Tretinoin results in increased expression of CRABP2 mRNA] CTD PMID:17942748 and PMID:7864861 Crabp2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CRABP2 mRNA CTD PMID:33387578 Crabp2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CRABP2 mRNA CTD PMID:32109520 and PMID:34747641 Crabp2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Crabp2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CRABP2 mRNA CTD PMID:17035482 and PMID:34363983 Crabp2 Rat 2,6-dimethoxyphenol multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [Sodium Chloride co-treated with pyrogallol 1 more ... CTD PMID:38598786 Crabp2 Rat 3,3',5,5'-tetrabromobisphenol A decreases expression ISO Crabp2 (Mus musculus) 6480464 tetrabromobisphenol A results in decreased expression of CRABP2 mRNA CTD PMID:25172293 Crabp2 Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CRABP2 mRNA CTD PMID:28628672 Crabp2 Rat 4,4'-sulfonyldiphenol decreases expression ISO CRABP2 (Homo sapiens) 6480464 bisphenol S results in decreased expression of CRABP2 mRNA CTD PMID:25912373 Crabp2 Rat 4,4'-sulfonyldiphenol decreases expression ISO Crabp2 (Mus musculus) 6480464 bisphenol S results in decreased expression of CRABP2 mRNA CTD PMID:30951980 Crabp2 Rat 4-tert-Octylphenol increases expression EXP 6480464 4-tert-octylphenol results in increased expression of CRABP2 mRNA CTD PMID:17011747 Crabp2 Rat 5-aza-2'-deoxycytidine affects expression ISO CRABP2 (Homo sapiens) 6480464 Decitabine affects the expression of CRABP2 mRNA CTD PMID:23300844 Crabp2 Rat 5-fluorouracil affects expression ISO Crabp2 (Mus musculus) 6480464 Fluorouracil affects the expression of CRABP2 protein CTD PMID:21296659 Crabp2 Rat 7,12-dimethyltetraphene increases expression ISO CRABP2 (Homo sapiens) 6480464 9 more ... CTD PMID:21527772 Crabp2 Rat 8'-apo-beta,psi-caroten-8'-al decreases expression ISO CRABP2 (Homo sapiens) 6480464 apocarotenal results in decreased expression of CRABP2 mRNA CTD PMID:17034753 Crabp2 Rat 9-cis-retinoic acid increases expression ISO CRABP2 (Homo sapiens) 6480464 Alitretinoin results in increased expression of CRABP2 mRNA CTD PMID:11214822 and PMID:17034753 Crabp2 Rat 9-cis-retinoic acid increases expression ISO Crabp2 (Mus musculus) 6480464 Alitretinoin results in increased expression of CRABP2 mRNA CTD PMID:16339527 Crabp2 Rat 9-cis-retinoic acid increases expression EXP 6480464 Alitretinoin analog results in increased expression of CRABP2 mRNA and Alitretinoin results in increased expression of CRABP2 mRNA CTD PMID:16946489 Crabp2 Rat acetic acid increases expression ISO Crabp2 (Mus musculus) 6480464 Acetic Acid results in increased expression of CRABP2 protein CTD PMID:21296659 Crabp2 Rat actinomycin D increases expression ISO CRABP2 (Homo sapiens) 6480464 Dactinomycin results in increased expression of CRABP2 mRNA CTD PMID:21527772 Crabp2 Rat actinomycin D multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [Dactinomycin co-treated with nutlin 3] results in increased expression of and results in increased secretion of CRABP2 protein and [Dactinomycin co-treated with nutlin 3] results in increased expression of CRABP2 mRNA CTD PMID:38460933 Crabp2 Rat adapalene increases expression ISO CRABP2 (Homo sapiens) 6480464 Adapalene results in increased expression of CRABP2 mRNA CTD PMID:8396608 and PMID:9990415 Crabp2 Rat aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of CRABP2 mRNA CTD PMID:23630614 Crabp2 Rat aflatoxin B1 increases expression ISO CRABP2 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of CRABP2 mRNA CTD PMID:21527772 and PMID:22100608 Crabp2 Rat alachlor increases expression EXP 6480464 alachlor results in increased expression of CRABP2 mRNA CTD PMID:12419858 Crabp2 Rat all-trans-4-oxoretinoic acid increases expression ISO CRABP2 (Homo sapiens) 6480464 4-oxoretinoic acid results in increased expression of CRABP2 mRNA CTD PMID:17034753 Crabp2 Rat all-trans-4-oxoretinol increases expression ISO CRABP2 (Homo sapiens) 6480464 4-oxoretinol results in increased expression of CRABP2 mRNA CTD PMID:17034753 Crabp2 Rat all-trans-retinoic acid affects expression EXP 6480464 Tretinoin affects the expression of CRABP2 mRNA CTD PMID:22262565 Crabp2 Rat all-trans-retinoic acid increases expression ISO CRABP2 (Homo sapiens) 6480464 Tretinoin results in increased expression of CRABP2 mRNA CTD PMID:11214822 more ... Crabp2 Rat all-trans-retinoic acid affects binding ISO CRABP2 (Homo sapiens) 6480464 Tretinoin binds to CRABP2 protein CTD PMID:15958702 Crabp2 Rat all-trans-retinoic acid multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [Tretinoin co-treated with alpha-Tocopherol] results in increased expression of CRABP2 mRNA more ... CTD PMID:15225641 more ... Crabp2 Rat all-trans-retinoic acid increases response to substance ISO CRABP2 (Homo sapiens) 6480464 CRABP2 protein results in increased susceptibility to Tretinoin CTD PMID:16166294 Crabp2 Rat all-trans-retinoic acid affects expression ISO Crabp2 (Mus musculus) 6480464 Tretinoin affects the expression of CRABP2 protein CTD PMID:15789344 Crabp2 Rat all-trans-retinoic acid affects binding ISO Crabp2 (Mus musculus) 6480464 Tretinoin binds to CRABP2 protein CTD PMID:17387344 Crabp2 Rat all-trans-retinoic acid increases expression EXP 6480464 Tretinoin analog results in increased expression of CRABP2 mRNA and Tretinoin results in increased expression of CRABP2 mRNA CTD PMID:16946489 and PMID:20488242 Crabp2 Rat all-trans-retinoic acid increases expression ISO Crabp2 (Mus musculus) 6480464 Tretinoin results in increased expression of CRABP2 and Tretinoin results in increased expression of CRABP2 mRNA CTD PMID:16038797 more ... Crabp2 Rat all-trans-retinoic acid multiple interactions ISO Crabp2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin inhibits the reaction [Tretinoin results in increased expression of CRABP2 mRNA] CTD PMID:7864861 Crabp2 Rat all-trans-retinol multiple interactions ISO CRABP2 (Homo sapiens) 6480464 CRABP2 protein promotes the reaction [Vitamin A results in increased expression of TOB1 mRNA] CTD PMID:17234770 Crabp2 Rat all-trans-retinol increases expression ISO CRABP2 (Homo sapiens) 6480464 Vitamin A results in increased expression of CRABP2 mRNA CTD PMID:16793012 and PMID:17034753 Crabp2 Rat alpha-Zearalanol multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CRABP2 mRNA CTD PMID:35163327 Crabp2 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CRABP2 mRNA CTD PMID:16483693 Crabp2 Rat antirheumatic drug increases expression ISO CRABP2 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of CRABP2 mRNA CTD PMID:24449571 Crabp2 Rat Aroclor 1254 increases expression ISO Crabp2 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CRABP2 mRNA CTD PMID:23650126 Crabp2 Rat arsane multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CRABP2 mRNA CTD PMID:32525701 Crabp2 Rat arsenic atom multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CRABP2 mRNA CTD PMID:32525701 Crabp2 Rat benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CRABP2 mRNA CTD PMID:21839799 Crabp2 Rat benzo[a]pyrene increases expression ISO CRABP2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of CRABP2 mRNA CTD PMID:32234424 Crabp2 Rat benzo[a]pyrene increases methylation ISO CRABP2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of CRABP2 5' UTR and Benzo(a)pyrene results in increased methylation of CRABP2 promoter CTD PMID:27901495 Crabp2 Rat benzo[a]pyrene decreases expression ISO Crabp2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of CRABP2 mRNA CTD PMID:25908611 Crabp2 Rat Benzo[k]fluoranthene decreases expression ISO Crabp2 (Mus musculus) 6480464 benzo(k)fluoranthene results in decreased expression of CRABP2 mRNA CTD PMID:26377693 Crabp2 Rat bis(2-chloroethyl) sulfide increases expression ISO Crabp2 (Mus musculus) 6480464 Mustard Gas results in increased expression of CRABP2 mRNA CTD PMID:15674843 Crabp2 Rat bis(2-chloroethyl) sulfide increases expression ISO CRABP2 (Homo sapiens) 6480464 Mustard Gas results in increased expression of CRABP2 mRNA CTD PMID:25102026 Crabp2 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CRABP2 mRNA CTD PMID:25181051 more ... Crabp2 Rat bisphenol A increases expression ISO CRABP2 (Homo sapiens) 6480464 bisphenol A results in increased expression of CRABP2 protein CTD PMID:37567409 Crabp2 Rat bisphenol A decreases expression ISO CRABP2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of CRABP2 protein CTD PMID:34186270 Crabp2 Rat bisphenol A increases expression ISO Crabp2 (Mus musculus) 6480464 bisphenol A results in increased expression of CRABP2 mRNA CTD PMID:26063408 Crabp2 Rat bisphenol AF decreases expression ISO CRABP2 (Homo sapiens) 6480464 bisphenol AF results in decreased expression of CRABP2 mRNA CTD PMID:25912373 Crabp2 Rat Bisphenol B increases expression ISO CRABP2 (Homo sapiens) 6480464 bisphenol B results in increased expression of CRABP2 protein CTD PMID:34186270 Crabp2 Rat bisphenol F multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CRABP2 mRNA CTD PMID:28628672 Crabp2 Rat bisphenol F decreases expression ISO Crabp2 (Mus musculus) 6480464 bisphenol F results in decreased expression of CRABP2 mRNA CTD PMID:30951980 Crabp2 Rat bromochloroacetic acid increases expression ISO Crabp2 (Mus musculus) 6480464 bromochloroacetic acid results in increased expression of CRABP2 protein CTD PMID:21296659 Crabp2 Rat butanal increases expression ISO CRABP2 (Homo sapiens) 6480464 butyraldehyde results in increased expression of CRABP2 mRNA CTD PMID:26079696 Crabp2 Rat cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of CRABP2 mRNA CTD PMID:33453195 Crabp2 Rat cadmium dichloride decreases expression ISO CRABP2 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of CRABP2 mRNA CTD PMID:38382870 Crabp2 Rat camptothecin increases expression ISO CRABP2 (Homo sapiens) 6480464 Camptothecin results in increased expression of CRABP2 mRNA CTD PMID:38460933 Crabp2 Rat chlordecone increases expression ISO Crabp2 (Mus musculus) 6480464 Chlordecone results in increased expression of CRABP2 mRNA CTD PMID:33711761 Crabp2 Rat cisplatin affects expression ISO CRABP2 (Homo sapiens) 6480464 Cisplatin affects the expression of CRABP2 mRNA CTD PMID:23300844 Crabp2 Rat copper atom multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in decreased expression of CRABP2 mRNA and [NSC 689534 binds to Copper] which results in decreased expression of CRABP2 mRNA CTD PMID:20971185 and PMID:24690739 Crabp2 Rat copper(0) multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in decreased expression of CRABP2 mRNA and [NSC 689534 binds to Copper] which results in decreased expression of CRABP2 mRNA CTD PMID:20971185 and PMID:24690739 Crabp2 Rat cyclophosphamide increases expression ISO CRABP2 (Homo sapiens) 6480464 Cyclophosphamide results in increased expression of CRABP2 mRNA CTD PMID:21527772 Crabp2 Rat cyclosporin A decreases methylation ISO CRABP2 (Homo sapiens) 6480464 Cyclosporine results in decreased methylation of CRABP2 promoter CTD PMID:27989131 Crabp2 Rat delta-tocopherol multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [Tretinoin co-treated with delta-tocopherol] results in increased expression of CRABP2 mRNA CTD PMID:15225641 Crabp2 Rat dexamethasone decreases expression ISO Crabp2 (Mus musculus) 6480464 Dexamethasone results in decreased expression of CRABP2 mRNA CTD PMID:20228061 and PMID:22733784 Crabp2 Rat dexamethasone multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CRABP2 mRNA CTD PMID:28628672 Crabp2 Rat dibenz[a,h]anthracene decreases expression ISO CRABP2 (Homo sapiens) 6480464 1 more ... CTD PMID:16269432 Crabp2 Rat Dibutyl phosphate affects expression ISO CRABP2 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of CRABP2 mRNA CTD PMID:37042841 Crabp2 Rat dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of CRABP2 mRNA and Dibutyl Phthalate results in decreased expression of CRABP2 protein CTD PMID:17379624 more ... Crabp2 Rat diethyl phthalate decreases expression EXP 6480464 diethyl phthalate results in decreased expression of CRABP2 mRNA CTD PMID:32341500 Crabp2 Rat diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CRABP2 mRNA CTD PMID:17011747 Crabp2 Rat disulfiram multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in decreased expression of CRABP2 mRNA CTD PMID:24690739 Crabp2 Rat dorsomorphin multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Crabp2 Rat elemental selenium increases expression EXP 6480464 Selenium deficiency results in increased expression of CRABP2 mRNA CTD PMID:11444866 Crabp2 Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of CRABP2 mRNA CTD PMID:29391264 Crabp2 Rat etoposide increases expression ISO CRABP2 (Homo sapiens) 6480464 Etoposide results in increased expression of CRABP2 mRNA CTD PMID:21527772 Crabp2 Rat ferric oxide increases expression EXP 6480464 ferric oxide analog results in increased expression of CRABP2 mRNA CTD PMID:38615722 Crabp2 Rat flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of CRABP2 mRNA CTD PMID:18035473 Crabp2 Rat flusilazole increases expression EXP 6480464 flusilazole results in increased expression of CRABP2 mRNA CTD PMID:22664269 Crabp2 Rat furan increases expression EXP 6480464 furan results in increased expression of CRABP2 mRNA CTD PMID:27387713 Crabp2 Rat furfural multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of CRABP2 protein and [Sodium Chloride co-treated with Furaldehyde] results in increased expression of CRABP2 protein CTD PMID:38598786 Crabp2 Rat gamma-tocopherol multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [Tretinoin co-treated with gamma-Tocopherol] results in increased expression of CRABP2 mRNA CTD PMID:15225641 Crabp2 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CRABP2 mRNA CTD PMID:33387578 Crabp2 Rat indometacin multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CRABP2 mRNA CTD PMID:28628672 Crabp2 Rat iron dichloride increases expression ISO CRABP2 (Homo sapiens) 6480464 ferrous chloride results in increased expression of CRABP2 mRNA CTD PMID:35984750 Crabp2 Rat isotretinoin increases expression ISO CRABP2 (Homo sapiens) 6480464 Isotretinoin results in increased expression of CRABP2 mRNA CTD PMID:17486130 Crabp2 Rat isotretinoin multiple interactions ISO CRABP2 (Homo sapiens) 6480464 R116010 promotes the reaction [Isotretinoin results in increased expression of CRABP2 mRNA] CTD PMID:17486130 Crabp2 Rat lipopolysaccharide multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CRABP2 mRNA CTD PMID:35811015 Crabp2 Rat methyl methanesulfonate increases expression ISO CRABP2 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of CRABP2 mRNA CTD PMID:21527772 Crabp2 Rat methylseleninic acid increases expression ISO CRABP2 (Homo sapiens) 6480464 methylselenic acid results in increased expression of CRABP2 mRNA CTD PMID:18548127 Crabp2 Rat mono(2-ethylhexyl) phthalate decreases expression ISO CRABP2 (Homo sapiens) 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of CRABP2 mRNA CTD PMID:36695872 Crabp2 Rat N-nitrosodiethylamine increases expression ISO CRABP2 (Homo sapiens) 6480464 Diethylnitrosamine results in increased expression of CRABP2 mRNA CTD PMID:21527772 Crabp2 Rat nickel sulfate decreases expression ISO CRABP2 (Homo sapiens) 6480464 nickel sulfate results in decreased expression of CRABP2 mRNA CTD PMID:22714537 Crabp2 Rat nicotine decreases expression ISO CRABP2 (Homo sapiens) 6480464 Nicotine results in decreased expression of CRABP2 mRNA CTD PMID:16949557 Crabp2 Rat Nutlin-3 multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [Dactinomycin co-treated with nutlin 3] results in increased expression of and results in increased secretion of CRABP2 protein and [Dactinomycin co-treated with nutlin 3] results in increased expression of CRABP2 mRNA CTD PMID:38460933 Crabp2 Rat olaparib affects response to substance ISO CRABP2 (Homo sapiens) 6480464 CRABP2 protein affects the susceptibility to olaparib CTD PMID:38493911 Crabp2 Rat olaparib multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [CRABP2 protein affects the susceptibility to olaparib] which affects the expression of and affects the cleavage of CASP8 protein more ... CTD PMID:38493911 Crabp2 Rat p-tert-Amylphenol increases expression EXP 6480464 4-tert-octylphenol results in increased expression of CRABP2 mRNA CTD PMID:17011747 Crabp2 Rat panobinostat multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CRABP2 mRNA CTD PMID:27188386 Crabp2 Rat panobinostat increases expression ISO CRABP2 (Homo sapiens) 6480464 panobinostat results in increased expression of CRABP2 mRNA CTD PMID:26272509 Crabp2 Rat pentane-2,3-dione increases expression EXP 6480464 2 and 3-pentanedione results in increased expression of CRABP2 mRNA CTD PMID:25710175 Crabp2 Rat perfluorohexanesulfonic acid increases expression ISO Crabp2 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of CRABP2 mRNA CTD PMID:37995155 Crabp2 Rat perfluorooctanoic acid multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CRABP2 mRNA CTD PMID:35163327 Crabp2 Rat perfluorooctanoic acid increases expression ISO CRABP2 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of CRABP2 mRNA CTD PMID:37738295 Crabp2 Rat potassium dichromate increases expression ISO CRABP2 (Homo sapiens) 6480464 Potassium Dichromate results in increased expression of CRABP2 protein CTD PMID:23718831 Crabp2 Rat progesterone decreases expression ISO Crabp2 (Mus musculus) 6480464 Progesterone results in decreased expression of CRABP2 mRNA CTD PMID:22238285 Crabp2 Rat progesterone multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of CRABP2 mRNA CTD PMID:17404688 Crabp2 Rat propanal increases expression ISO CRABP2 (Homo sapiens) 6480464 propionaldehyde results in increased expression of CRABP2 mRNA CTD PMID:26079696 Crabp2 Rat resveratrol increases expression ISO CRABP2 (Homo sapiens) 6480464 resveratrol results in increased expression of CRABP2 mRNA CTD PMID:12002526 and PMID:15280659 Crabp2 Rat resveratrol increases expression ISO Crabp2 (Mus musculus) 6480464 resveratrol results in increased expression of CRABP2 protein CTD PMID:25505154 Crabp2 Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CRABP2 mRNA CTD PMID:35811015 Crabp2 Rat SB 431542 multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:37664457 Crabp2 Rat selenium atom increases expression EXP 6480464 Selenium deficiency results in increased expression of CRABP2 mRNA CTD PMID:11444866 Crabp2 Rat silicon dioxide increases expression ISO CRABP2 (Homo sapiens) 6480464 Silicon Dioxide results in increased expression of CRABP2 mRNA CTD PMID:34973136 Crabp2 Rat sodium arsenate multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CRABP2 mRNA CTD PMID:32525701 Crabp2 Rat sodium arsenite affects methylation ISO CRABP2 (Homo sapiens) 6480464 sodium arsenite affects the methylation of CRABP2 gene CTD PMID:28589171 Crabp2 Rat sodium arsenite decreases expression ISO Crabp2 (Mus musculus) 6480464 sodium arsenite results in decreased expression of CRABP2 mRNA CTD PMID:37682722 Crabp2 Rat sodium arsenite increases expression ISO CRABP2 (Homo sapiens) 6480464 sodium arsenite results in increased expression of CRABP2 mRNA CTD PMID:38568856 Crabp2 Rat sodium arsenite decreases expression ISO CRABP2 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of CRABP2 mRNA CTD PMID:12016162 Crabp2 Rat sodium chloride multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of CRABP2 protein more ... CTD PMID:38598786 Crabp2 Rat sodium dodecyl sulfate decreases expression ISO CRABP2 (Homo sapiens) 6480464 Sodium Dodecyl Sulfate results in decreased expression of CRABP2 mRNA CTD PMID:31734321 Crabp2 Rat sulforaphane decreases expression ISO CRABP2 (Homo sapiens) 6480464 sulforaphane results in decreased expression of CRABP2 mRNA CTD PMID:31838189 Crabp2 Rat sunitinib decreases expression ISO CRABP2 (Homo sapiens) 6480464 Sunitinib results in decreased expression of CRABP2 mRNA CTD PMID:31533062 Crabp2 Rat temozolomide decreases expression ISO CRABP2 (Homo sapiens) 6480464 Temozolomide results in decreased expression of CRABP2 mRNA CTD PMID:31758290 Crabp2 Rat tetrathiomolybdate(2-) decreases expression ISO CRABP2 (Homo sapiens) 6480464 tetrathiomolybdate analog results in decreased expression of CRABP2 mRNA CTD PMID:19323979 Crabp2 Rat thapsigargin decreases expression ISO CRABP2 (Homo sapiens) 6480464 Thapsigargin results in decreased expression of CRABP2 mRNA CTD PMID:22378314 Crabp2 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CRABP2 mRNA CTD PMID:34492290 Crabp2 Rat thiram increases expression ISO CRABP2 (Homo sapiens) 6480464 Thiram results in increased expression of CRABP2 mRNA CTD PMID:38568856 Crabp2 Rat titanium dioxide decreases methylation ISO CRABP2 (Homo sapiens) 6480464 titanium dioxide results in decreased methylation of CRABP2 gene CTD PMID:34973136 Crabp2 Rat titanium dioxide increases expression ISO CRABP2 (Homo sapiens) 6480464 titanium dioxide results in increased expression of CRABP2 mRNA CTD PMID:34973136 Crabp2 Rat tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of CRABP2 mRNA CTD PMID:21683754 Crabp2 Rat trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of CRABP2 mRNA CTD PMID:33387578 Crabp2 Rat trichostatin A increases expression ISO CRABP2 (Homo sapiens) 6480464 trichostatin A results in increased expression of CRABP2 mRNA CTD PMID:24935251 and PMID:26272509 Crabp2 Rat trichostatin A multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CRABP2 mRNA CTD PMID:27188386 Crabp2 Rat triclosan decreases expression ISO CRABP2 (Homo sapiens) 6480464 Triclosan results in decreased expression of CRABP2 mRNA CTD PMID:30510588 Crabp2 Rat triphenyl phosphate affects expression ISO CRABP2 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of CRABP2 mRNA CTD PMID:37042841 Crabp2 Rat triptonide increases expression ISO Crabp2 (Mus musculus) 6480464 triptonide results in increased expression of CRABP2 mRNA CTD PMID:33045310 Crabp2 Rat tunicamycin decreases expression ISO CRABP2 (Homo sapiens) 6480464 Tunicamycin results in decreased expression of CRABP2 mRNA CTD PMID:22378314 Crabp2 Rat valproic acid increases expression ISO Crabp2 (Mus musculus) 6480464 Valproic Acid results in increased expression of CRABP2 mRNA CTD PMID:21427059 and PMID:24896083 Crabp2 Rat valproic acid affects expression ISO CRABP2 (Homo sapiens) 6480464 Valproic Acid affects the expression of CRABP2 mRNA CTD PMID:25979313 Crabp2 Rat valproic acid increases methylation ISO CRABP2 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of CRABP2 gene CTD PMID:29154799 Crabp2 Rat valproic acid increases expression ISO CRABP2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of CRABP2 mRNA CTD PMID:23179753 more ... Crabp2 Rat valproic acid multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CRABP2 mRNA CTD PMID:27188386 Crabp2 Rat vorinostat increases expression ISO CRABP2 (Homo sapiens) 6480464 vorinostat results in increased expression of CRABP2 mRNA CTD PMID:26272509 Crabp2 Rat vorinostat multiple interactions ISO CRABP2 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CRABP2 mRNA CTD PMID:27188386 Crabp2 Rat zearalenone decreases expression ISO Crabp2 (Mus musculus) 6480464 Zearalenone results in decreased expression of CRABP2 protein CTD PMID:36252740
(R,R,R)-alpha-tocopherol (ISO) (S)-nicotine (ISO) 1,2-dichloroethane (ISO) 17alpha-ethynylestradiol (ISO) 17beta-estradiol (ISO) 2,3',4,4',5-Pentachlorobiphenyl (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,6-dimethoxyphenol (ISO) 3,3',5,5'-tetrabromobisphenol A (ISO) 3-isobutyl-1-methyl-7H-xanthine (ISO) 4,4'-sulfonyldiphenol (ISO) 4-tert-Octylphenol (EXP) 5-aza-2'-deoxycytidine (ISO) 5-fluorouracil (ISO) 7,12-dimethyltetraphene (ISO) 8'-apo-beta,psi-caroten-8'-al (ISO) 9-cis-retinoic acid (EXP,ISO) acetic acid (ISO) actinomycin D (ISO) adapalene (ISO) aflatoxin B1 (EXP,ISO) alachlor (EXP) all-trans-4-oxoretinoic acid (ISO) all-trans-4-oxoretinol (ISO) all-trans-retinoic acid (EXP,ISO) all-trans-retinol (ISO) alpha-Zearalanol (EXP) ammonium chloride (EXP) antirheumatic drug (ISO) Aroclor 1254 (ISO) arsane (ISO) arsenic atom (ISO) benzo[a]pyrene (EXP,ISO) Benzo[k]fluoranthene (ISO) bis(2-chloroethyl) sulfide (ISO) bisphenol A (EXP,ISO) bisphenol AF (ISO) Bisphenol B (ISO) bisphenol F (ISO) bromochloroacetic acid (ISO) butanal (ISO) cadmium dichloride (EXP,ISO) camptothecin (ISO) chlordecone (ISO) cisplatin (ISO) copper atom (ISO) copper(0) (ISO) cyclophosphamide (ISO) cyclosporin A (ISO) delta-tocopherol (ISO) dexamethasone (ISO) dibenz[a,h]anthracene (ISO) Dibutyl phosphate (ISO) dibutyl phthalate (EXP) diethyl phthalate (EXP) diethylstilbestrol (EXP) disulfiram (ISO) dorsomorphin (ISO) elemental selenium (EXP) endosulfan (EXP) etoposide (ISO) ferric oxide (EXP) flavonoids (EXP) flusilazole (EXP) furan (EXP) furfural (ISO) gamma-tocopherol (ISO) gentamycin (EXP) indometacin (ISO) iron dichloride (ISO) isotretinoin (ISO) lipopolysaccharide (ISO) methyl methanesulfonate (ISO) methylseleninic acid (ISO) mono(2-ethylhexyl) phthalate (ISO) N-nitrosodiethylamine (ISO) nickel sulfate (ISO) nicotine (ISO) Nutlin-3 (ISO) olaparib (ISO) p-tert-Amylphenol (EXP) panobinostat (ISO) pentane-2,3-dione (EXP) perfluorohexanesulfonic acid (ISO) perfluorooctanoic acid (EXP,ISO) potassium dichromate (ISO) progesterone (ISO) propanal (ISO) resveratrol (ISO) S-(1,2-dichlorovinyl)-L-cysteine (ISO) SB 431542 (ISO) selenium atom (EXP) silicon dioxide (ISO) sodium arsenate (ISO) sodium arsenite (ISO) sodium chloride (ISO) sodium dodecyl sulfate (ISO) sulforaphane (ISO) sunitinib (ISO) temozolomide (ISO) tetrathiomolybdate(2-) (ISO) thapsigargin (ISO) thioacetamide (EXP) thiram (ISO) titanium dioxide (ISO) tributylstannane (EXP) trichloroethene (EXP) trichostatin A (ISO) triclosan (ISO) triphenyl phosphate (ISO) triptonide (ISO) tunicamycin (ISO) valproic acid (ISO) vorinostat (ISO) zearalenone (ISO)
1.
Expression of the cellular retinoic acid binding proteins, type II and type I, in mature rat olfactory epithelium.
Asson-Batres MA, etal., Cell Tissue Res 2003 Apr;312(1):9-19. Epub 2003 Mar 18.
2.
Inducible expression of cellular retinoic acid-binding protein II in rat ovary: gonadotropin regulation during luteal development.
Bucco RA, etal., Endocrinology 1995 Jun;136(6):2730-40.
3.
Affinity purification of retinoic acid-binding proteins using immobilized 4-(2-hydroxyethoxy)retinoic acid.
Chapman JM and Curley RW Jr, Protein Expr Purif. 1990 Sep;1(1):63-9.
4.
Immunolocalization of retinoic acid biosynthesis systems in selected sites in rat.
Everts HB, etal., Exp Cell Res. 2005 Aug 15;308(2):309-19.
5.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
6.
Rat ISS GO annotations from GOA human gene data--August 2006
GOA data from the GO Consortium
7.
Rat ISS GO annotations from MGI mouse gene data--August 2006
MGD data from the GO Consortium
8.
Physiological insights into all-trans-retinoic acid biosynthesis.
Napoli JL Biochim Biophys Acta. 2012 Jan;1821(1):152-67. Epub 2011 May 19.
9.
Electronic Transfer of LocusLink and RefSeq Data
NCBI rat LocusLink and RefSeq merged data July 26, 2002
10.
GOA pipeline
RGD automated data pipeline
11.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
12.
Tentative Sequence Identification Numbers
Tentative Sequence Data IDs. TIGR Gene Index, Rat Data
Crabp2 Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 2 175,714,862 - 175,719,208 (+) NCBI GRCr8 mRatBN7.2 2 173,417,004 - 173,421,352 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 2 173,416,857 - 173,421,379 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 2 180,561,789 - 180,566,132 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 2 178,584,144 - 178,588,487 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 2 173,184,231 - 173,188,583 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 2 187,322,416 - 187,326,794 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 2 184,882,969 - 184,883,505 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 2 204,274,043 - 204,274,530 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 2 180,029,801 - 180,034,147 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 2 167,367,701 - 167,368,833 (+) NCBI Celera Cytogenetic Map 2 q34 NCBI
CRABP2 Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 1 156,699,606 - 156,705,784 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 1 156,699,606 - 156,705,816 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 1 156,669,398 - 156,675,576 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 1 154,936,027 - 154,941,999 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 1 153,482,482 - 153,488,448 NCBI Celera 1 129,740,204 - 129,746,174 (-) NCBI Celera Cytogenetic Map 1 q23.1 NCBI HuRef 1 128,026,950 - 128,033,158 (-) NCBI HuRef CHM1_1 1 158,065,590 - 158,071,800 (-) NCBI CHM1_1 T2T-CHM13v2.0 1 155,836,009 - 155,842,185 (-) NCBI T2T-CHM13v2.0
Crabp2 Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 3 87,856,000 - 87,860,679 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 3 87,855,973 - 87,860,683 (+) Ensembl GRCm39 Ensembl GRCm38 3 87,948,693 - 87,953,372 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 3 87,948,666 - 87,953,376 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 3 87,752,615 - 87,757,294 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 3 88,034,620 - 88,039,299 (+) NCBI MGSCv36 mm8 Celera 3 87,986,089 - 87,990,775 (+) NCBI Celera Cytogenetic Map 3 F1 NCBI cM Map 3 38.78 NCBI
Crabp2 Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955545 2,777,474 - 2,782,567 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955545 2,777,523 - 2,782,567 (-) NCBI ChiLan1.0 ChiLan1.0
CRABP2 Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 1 93,136,641 - 93,145,036 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 1 92,873,250 - 92,879,530 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 1 132,043,097 - 132,049,366 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 1 135,864,795 - 135,870,145 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 1 135,864,807 - 135,870,145 (-) Ensembl panpan1.1 panPan2
CRABP2 Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 7 41,277,580 - 41,282,158 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 7 41,277,644 - 41,281,833 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 7 40,764,747 - 40,769,752 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 7 41,140,579 - 41,145,585 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 7 41,141,033 - 41,145,716 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 7 40,922,537 - 40,927,542 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 7 40,975,475 - 40,980,469 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 7 41,259,166 - 41,264,171 (+) NCBI UU_Cfam_GSD_1.0
Crabp2 Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405058 26,830,604 - 26,836,454 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936580 5,860,562 - 5,866,856 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936580 5,861,051 - 5,866,818 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
CRABP2 Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 4 93,388,092 - 93,394,155 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 4 93,388,198 - 93,393,861 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 4 101,960,067 - 101,965,733 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3 Pig Cytomap 4 q21-q23 NCBI
CRABP2 Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 20 7,159,022 - 7,164,586 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 20 7,159,238 - 7,164,163 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666038 6,452,658 - 6,458,227 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Crabp2
.
Predicted Target Of
Count of predictions: 262 Count of miRNA genes: 167 Interacting mature miRNAs: 181 Transcripts: ENSRNOT00000025183, ENSRNOT00000072198 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1578648 Bss11 Bone structure and strength QTL 11 4.7 femur morphology trait (VT:0000559) femoral neck cortical cross-sectional area (CMO:0001702) 2 114837527 211674221 Rat 1358356 Srcrt1 Stress Responsive Cort QTL1 3.66 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 2 161699179 222436696 Rat 1331734 Bp204 Blood pressure QTL 204 3.61192 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 2 168358098 223265385 Rat 1298074 Bp164 Blood pressure QTL 164 0.003 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 42804607 202447032 Rat 6907363 Bp357 Blood pressure QTL 357 4.1 0.002 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 2 129540907 174540907 Rat 1354648 Bp239 Blood pressure QTL 239 0.001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 66118463 226797303 Rat 1354649 Kidm17 Kidney mass QTL 17 2.9 kidney mass (VT:0002707) calculated kidney weight (CMO:0000160) 2 81754530 227146641 Rat 10755499 Bp389 Blood pressure QTL 389 2.61 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 2 18960362 228801039 Rat 1298076 Bp166 Blood pressure QTL 166 0.0009 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 136445150 202447032 Rat 152025245 Scl81 Serum cholesterol level QTL 81 3.49 blood cholesterol amount (VT:0000180) 2 122609194 206936711 Rat 70162 Bp63 Blood pressure QTL 63 5.64 arterial blood pressure trait (VT:2000000) blood pressure measurement (CMO:0000003) 2 169745596 214745596 Rat 1554319 Bmd2 Bone mineral density QTL 2 13.4 0.0001 lumbar vertebra area (VT:0010570) lumbar vertebra cross-sectional area (CMO:0001689) 2 114837675 212549332 Rat 12879836 Kidm61 Kidney mass QTL 61 0.001 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 152413072 185122374 Rat 1581569 Uae32 Urinary albumin excretion QTL 32 0.0001 urine protein amount (VT:0005160) urine albumin excretion rate (CMO:0000757) 2 78665619 219826953 Rat 10043136 Iddm54 Insulin dependent diabetes mellitus QTL 54 3.4 0.0001 blood glucose amount (VT:0000188) age at onset/diagnosis of type 1 diabetes mellitus (CMO:0001140) 2 143657411 190602963 Rat 12879837 Am2 Aortic mass QTL 2 0.001 aorta mass (VT:0002845) aorta weight to aorta length to body weight ratio (CMO:0002722) 2 152413072 185122374 Rat 12879838 Cm86 Cardiac mass QTL 86 0.002 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 2 152413072 185122374 Rat 1302793 Bw16 Body weight QTL 16 5 0.0001 body mass (VT:0001259) body weight (CMO:0000012) 2 157142209 202446871 Rat 61467 Bp14 Blood pressure QTL 14 2.2 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 43154682 202446871 Rat 12879839 Cm85 Cardiac mass QTL 85 0.001 heart mass (VT:0007028) heart wet weight to body weight ratio (CMO:0002408) 2 152413072 185122374 Rat 61469 Bp16 Blood pressure QTL 16 5.64 arterial blood pressure trait (VT:2000000) blood pressure measurement (CMO:0000003) 2 169745596 214745596 Rat 70175 BpQTLCluster3 Blood pressure QTL cluster 3 4.128 arterial blood pressure trait (VT:2000000) absolute change in systolic blood pressure (CMO:0000607) 2 135552573 202446871 Rat 1549833 Bp257 Blood pressure QTL 257 0.003 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 2 168354880 185122374 Rat 1358900 Bw48 Body weight QTL 48 4.88 body mass (VT:0001259) body weight (CMO:0000012) 2 157142078 211086598 Rat 12879845 Cm89 Cardiac mass QTL 89 0.008 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 2 152413072 175950118 Rat 61473 Bp19 Blood pressure QTL 19 6.3 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 172710921 175950118 Rat 1359030 Bp277 Blood pressure QTL 277 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 2 114837527 185876470 Rat 12879846 Cm90 Cardiac mass QTL 90 0.011 heart right ventricle mass (VT:0007033) heart right ventricle weight to body weight ratio (CMO:0000914) 2 152413072 175950118 Rat 12879847 Am4 Aortic mass QTL 4 0.001 aorta mass (VT:0002845) aorta weight to aorta length to body weight ratio (CMO:0002722) 2 152413072 175950118 Rat 1331760 Bp206 Blood pressure QTL 206 3.62454 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 2 56043031 202447032 Rat 12879840 Bw179 Body weight QTL 179 0.005 body mass (VT:0001259) body weight (CMO:0000012) 2 152413072 185122374 Rat 1581502 Esta3 Estrogen-induced thymic atrophy QTL 3 thymus mass (VT:0004954) thymus wet weight (CMO:0000855) 2 136916935 189599348 Rat 1359032 Hrtrt18 Heart rate QTL 18 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 2 157142078 192625452 Rat 2301966 Bp322 Blood pressure QTL 322 3.58 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 150540301 202447032 Rat 1298080 Bp163 Blood pressure QTL 163 0.02 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 66118275 202447032 Rat 8662832 Vetf7 Vascular elastic tissue fragility QTL 7 3.5 aorta elastin amount (VT:0003905) aorta wall extracellular elastin dry weight to aorta wall dry weight ratio (CMO:0002002) 2 81689826 221035911 Rat 1298085 Bp165 Blood pressure QTL 165 0.0006 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 42804607 202447032 Rat 1359022 Ppulsi1 Prepulse inhibition QTL 1 3.63 prepulse inhibition trait (VT:0003088) acoustic startle response measurement (CMO:0001519) 2 136916935 213594495 Rat 1641891 Alcrsp17 Alcohol response QTL 17 response to alcohol trait (VT:0010489) duration of loss of righting reflex (CMO:0002289) 2 149559561 249053267 Rat 724534 Uae6 Urinary albumin excretion QTL 6 10 urine albumin amount (VT:0002871) urine albumin level (CMO:0000130) 2 78665619 249053267 Rat 61374 Edpm2 Estrogen-dependent pituitary mass QTL 2 4.42 0.86 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 2 76539322 202447032 Rat 8662843 Vetf9 Vascular elastic tissue fragility QTL 9 2.05 thoracic aorta molecular composition trait (VT:0010568) aorta wall extracellular elastin dry weight to aorta wall extracellular collagen weight ratio (CMO:0002003) 2 157142078 226277316 Rat 631501 Bp101 Blood pressure QTL 101 2.4 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 150341684 202446871 Rat 2301415 Cm67 Cardiac mass QTL 67 0.003 heart mass (VT:0007028) heart wet weight to body weight ratio (CMO:0002408) 2 152413072 175950118 Rat 2307174 Activ3 Activity QTL 3 4.83 0.000058 locomotor behavior trait (VT:0001392) number of entries into a discrete space in an experimental apparatus (CMO:0000960) 2 168594495 213594495 Rat 1331794 Bp202 Blood pressure QTL 202 3.66819 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 141194931 223265385 Rat 71113 Cari2 Carrageenan-induced inflammation QTL 2 2.7 0.009 hypodermis integrity trait (VT:0010550) inflammatory exudate volume (CMO:0001429) 2 141596551 202447032 Rat 1331805 Cm29 Cardiac mass QTL 29 3.50746 heart mass (VT:0007028) heart wet weight (CMO:0000069) 2 141194931 223265385 Rat 11565180 Kidm56 Kidney mass QTL 56 0.003 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 2 152413072 175950118 Rat 634308 Sach6 Saccharin preference QTL 6 4.9 taste sensitivity trait (VT:0001986) saccharin intake volume to total fluid intake volume ratio (CMO:0001601) 2 112456140 212696837 Rat 1598805 Memor8 Memory QTL 8 3 exploratory behavior trait (VT:0010471) average horizontal distance between subject and target during voluntary locomotion in an experimental apparatus (CMO:0002674) 2 150341585 189039377 Rat 11565181 Bw176 Body weight QTL 176 0.002 body mass (VT:0001259) body weight (CMO:0000012) 2 152413072 175950118 Rat 1358917 Cm42 Cardiac mass QTL 42 2.82 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 203928301 Rat 724568 Uae13 Urinary albumin excretion QTL 13 4.4 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 2 143157029 210020885 Rat 1358913 Cm41 Cardiac mass QTL 41 2.73 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 2 25413423 203928301 Rat 1300165 Rf9 Renal function QTL 9 3.28 kidney glomerulus integrity trait (VT:0010546) index of glomerular damage (CMO:0001135) 2 133914684 202447032 Rat 61401 Niddm2 Non-insulin dependent diabetes mellitus QTL 2 4.54 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 2 144599348 189599348 Rat 631507 Bp105 Blood pressure QTL 105 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 2 112456140 212696837 Rat 1641925 Alcrsp2 Alcohol response QTL 2 response to alcohol trait (VT:0010489) duration of loss of righting reflex (CMO:0002289) 2 149559561 221167075 Rat 1354609 Niddm62 Non-insulin dependent diabetes mellitus QTL 62 4.72 0.000006 insulin secretion trait (VT:0003564) plasma insulin level (CMO:0000342) 2 150540301 202447032 Rat 1598833 Bp295 Blood pressure QTL 295 3.5 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 147798556 192798556 Rat 1354622 Kidm16 Kidney mass QTL 16 3 kidney mass (VT:0002707) left kidney wet weight (CMO:0000083) 2 81754530 222436696 Rat 631266 Bp132 Blood pressure QTL 132 0.0005 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 46123260 202447032 Rat 631522 Bp74 Blood pressure QTL 74 0.05 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 172710921 184114403 Rat 7488927 Bp365 Blood pressure QTL 365 0.008 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 2 162765032 207765032 Rat 1598838 Bp290 Blood pressure QTL 290 1.9 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 166539266 211539266 Rat 7488925 Bp364 Blood pressure QTL 364 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 2 160564068 205564068 Rat 2293843 Kiddil6 Kidney dilation QTL 6 3.1 kidney pelvis morphology trait (VT:0004194) hydronephrosis severity score (CMO:0001208) 2 42804607 182042367 Rat 2306901 Bp337 Blood pressure QTL 337 0.01 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 2 164073756 227146641 Rat 1354605 Rf48 Renal function QTL 48 2.9 blood creatinine amount (VT:0005328) plasma creatinine level (CMO:0000537) 2 74786664 206665859 Rat 6903312 Bw112 Body weight QTL 112 3.2 0.0013 body mass (VT:0001259) body weight (CMO:0000012) 2 143657569 184114274 Rat 7488904 Bp363 Blood pressure QTL 363 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 2 172982062 175950118 Rat 1354601 Slep1 Serum leptin concentration QTL 1 5.39 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 2 43171017 184114403 Rat
Crabp2
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 173,420,231 - 173,420,615 (+) MAPPER mRatBN7.2 Rnor_6.0 2 184,882,982 - 184,883,365 NCBI Rnor6.0 Rnor_6.0 2 187,325,642 - 187,326,025 NCBI Rnor6.0 Rnor_5.0 2 204,274,055 - 204,274,438 UniSTS Rnor5.0 Rnor_5.0 2 206,728,659 - 206,729,042 UniSTS Rnor5.0 RGSC_v3.4 2 180,033,027 - 180,033,410 UniSTS RGSC3.4 Celera 2 167,367,713 - 167,368,096 UniSTS Cytogenetic Map 2 q34 UniSTS
RH142909
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 2 173,421,747 - 173,421,849 (+) MAPPER mRatBN7.2 Rnor_6.0 2 187,327,158 - 187,327,259 NCBI Rnor6.0 Rnor_5.0 2 206,730,175 - 206,730,276 UniSTS Rnor5.0 RGSC_v3.4 2 180,034,543 - 180,034,644 UniSTS RGSC3.4 Celera 2 167,369,229 - 167,369,330 UniSTS RH 3.4 Map 2 1129.2 UniSTS Cytogenetic Map 2 q34 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
16
12
77
185
125
122
76
34
76
12
315
147
153
68
103
46
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000025183 ⟹ ENSRNOP00000015134
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 2 173,416,857 - 173,421,379 (+) Ensembl Rnor_6.0 Ensembl 2 187,322,416 - 187,326,789 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000072198 ⟹ ENSRNOP00000067258
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source Rnor_6.0 Ensembl 2 184,882,969 - 184,883,505 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000105111 ⟹ ENSRNOP00000086398
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 2 173,419,429 - 173,421,379 (+) Ensembl
RefSeq Acc Id:
NM_017244 ⟹ NP_058940
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 2 175,714,862 - 175,719,208 (+) NCBI mRatBN7.2 2 173,417,004 - 173,421,352 (+) NCBI Rnor_6.0 2 187,322,416 - 187,326,762 (+) NCBI Rnor_5.0 2 204,274,043 - 204,274,530 (+) NCBI RGSC_v3.4 2 180,029,801 - 180,034,147 (+) RGD Celera 2 167,367,701 - 167,368,833 (+) RGD
Sequence:
CGGAATTCCGATCTGTTCTGCAAAGGGGACAGCAAGGTACCTTTAGGCTAAAGGACTCGGCGTCCAGTATTCTAGTTGAAGATCTAAAGAGAAAGCCACCTTGCTGCCACTATGCCTAACTTTTCTGG
hide sequence
RefSeq Acc Id:
NP_058940 ⟸ NM_017244
- UniProtKB:
P51673 (UniProtKB/Swiss-Prot), A0A8L2Q848 (UniProtKB/TrEMBL)
- Sequence:
MPNFSGNWKIIRSENFEEMLKALGVNMMMRKIAVAAASKPAVEIKQENDDTFYIKTSTTVRTTEINFKIGEEFEEQTVDGRPCKSLVKWESENKMVCEQRLLKGEGPKTSWSRELTNDGELILTMTAD
hide sequence
Ensembl Acc Id:
ENSRNOP00000067258 ⟸ ENSRNOT00000072198
Ensembl Acc Id:
ENSRNOP00000015134 ⟸ ENSRNOT00000025183
Ensembl Acc Id:
ENSRNOP00000086398 ⟸ ENSRNOT00000105111
RGD ID: 13691431 Promoter ID: EPDNEW_R1949 Type: single initiation site Name: Crabp2_1 Description: cellular retinoic acid binding protein 2 SO ACC ID: SO:0000170 Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ ) Experiment Methods: Single-end sequencing. Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 2 187,322,372 - 187,322,432 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2021-03-09
Crabp2
cellular retinoic acid binding protein 2
LOC108348208
cellular retinoic acid-binding protein 2-like
Data merged from RGD:11355364
737654 PROVISIONAL
2016-08-02
LOC108348208
cellular retinoic acid-binding protein 2-like
Symbol and Name status set to provisional
70820 PROVISIONAL
2004-12-14
Crabp2
cellular retinoic acid binding protein 2
Symbol and Name status set to approved
1299863 APPROVED
2002-06-10
Crabp2
cellular retinoic acid binding protein 2
Name updated
70585 PROVISIONAL
Note Type
Note
Reference
gene_expression
expressed at high levels in the corpus luteum
61557
